BioSpace News Archive

Anavex Life Sciences Corp. announced that the United States Patent and Trademark Office granted U.S. Patent No. 10,507,196 to support Anavex’s leading drug candidate, ANAVEX®2-73 for the treatment of neurodevelopmental disorders including Rett syndrome, and multiple sclerosis.

Sol-Gel Technologies, Ltd. will host a conference call to discuss results from two Phase 3 clinical trials for Twyneo®, an investigational combination of microencapsulated tretinoin 0.1% and microencapsulated benzoyl peroxide 3% cream being studied in patients with acne vulgaris.

Avanos Medical, Inc. announced that Joe Woody, chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday Jan. 15 at approximately 2 p.m. PT at the Westin St. Francis Hotel in San Francisco.

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced the appointment of Oliver Froescheis, Ph.D., as Senior Vice President, Corporate and Business Development.

Foundation to custom design and provide “n-of 1" experimental ASO medicines to patients with extremely rare diseases for free

Mayo Clinic and NTT Venture Capital join Matrix Partners and Matrix Capital Management as investors in nference

Expands portfolio of chemistry services from compound design to clinical proof of concept

Genome Medical, a leader in telegenomics clinical care, announced that it has expanded its commercial team to meet the growing demand from health care providers to integrate genomics into everyday care.

HUYA Bioscience International CEO & Executive Chair, Dr. Mireille Gillings announced the appointment of Meiji Seika Pharma as an exclusive distributor for its lymphoma product, HBI-8000, in Japan.

Kala Pharmaceuticals, Inc. announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Mark Iwicki, Chairman, President and Chief Executive Officer of Kala Pharmaceuticals, is scheduled to present a corporate overview on Wednesday, January 15, 2020 at 11:30 a.m. PT.